Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-13 10:15 am Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | ALKEON CAPITAL MANAGEMENT LLC | 2,399,252 6.1% | 2,399,252![]() (New Position) | View |
2023-02-10 1:56 pm Sale | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital LLC | 3,418,068 7.6% | -50,876![]() (-1.47%) | View |
2023-02-09 12:01 pm Sale | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 4,016,608 10.148% | -1,890,671![]() (-32.01%) | View |
2023-02-06 09:50 am Sale | 13G | ORIC Pharmaceuticals, Inc. ORIC | VICTORY CAPITAL MANAGEMENT INC | 3,459 0.01% | -2,297,773![]() (-99.85%) | View |
2023-01-20 4:09 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | MILLENNIUM MANAGEMENT LLC | 2,433,850 5.4% | 2,433,850![]() (New Position) | View |
2022-12-29 4:41 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | PFIZER INC PFE | 5,376,344 12% | 5,376,344![]() (New Position) | View |
2022-12-27 4:36 pm Sale | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 1,787,569 4.5% | -425,002![]() (-19.21%) | View |
2022-07-08 4:57 pm Sale | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 799,341 2% | -1,616,006![]() (-66.91%) | View |
2022-02-14 3:02 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital LLC | 3,468,944 8.8% | 376,726![]() (+12.18%) | View |
2022-02-11 4:54 pm Sale | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 3,671,522 9.3% | -1,096,659![]() (-23.00%) | View |
2022-02-09 10:24 am Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 5,907,279 14.999% | 454,932![]() (+8.34%) | View |
2022-02-03 4:41 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 2,415,347 6.1% | 536,439![]() (+28.55%) | View |
2022-02-02 3:53 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | VICTORY CAPITAL MANAGEMENT INC | 2,301,232 5.84% | 2,301,232![]() (New Position) | View |
2021-08-12 4:17 pm Sale | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,212,571 5.6% | -254,721![]() (-10.32%) | View |
2021-03-19 6:06 pm Sale | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,467,292 6.8% | -298,425![]() (-10.79%) | View |
2021-02-16 12:07 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital LLC | 3,092,218 8.7% | 450,000![]() (+17.03%) | View |
2021-02-12 6:24 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 4,768,181 13.1% | 4,768,181![]() (New Position) | View |
2021-02-08 10:29 am Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 5,452,347 14.999% | 2,215,014![]() (+68.42%) | View |
2021-02-02 3:13 pm Purchase | 13G | ORIC Pharmaceuticals, Inc. ORIC | BlackRock Inc. BLK | 1,878,908 5.3% | 1,878,908![]() (New Position) | View |
2020-11-18 2:42 pm Unchanged | 13D | ORIC Pharmaceuticals, Inc. ORIC | ORBIMED ADVISORS LLC | 2,765,717 7.8% | 0 (Unchanged) | View |